Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Painful Diabetic Peripheral Neuropathy
Interventions
DRUG

pregabalin

150 - 300 mg/day in divided dose (3 time a day) for 6 weeks

DRUG

placebo

matching placebo 3 time a day

Trial Locations (61)

10128

The Medical Research Network, LLC, New York

16602

Blair Orthopedic Associates, Inc., Altoona

16635

Altoona Center for Clinical Research, Duncansville

27292

Davidson Medical Ministries, Lexington

29118

Neurology and Pain Clinic, LLC, Orangeburg

31904

Columbus Research Foundation, Columbus

33009

MD Clinical, Hallandale

33012

AGA Clinical Trials, Hialeah

33418

Palm Beach Neurological Center,, Palm Beach Gardens

33606

Meridien Research, Tampa

33709

Meridien Research, St. Petersburg

33880

Clinical Research of Central Florida, Winter Haven

33912

Gulfcoast Clinical Research Center, Fort Myers

34208

Meridien Research, Bradenton

34601

Meridien Research, Brooksville

37919

New Phase Research and Development, Knoxville

39301

UNARS, s.r.o., Pelhřimov

40509

Central Kentucky Research Associates, Inc., Lexington

43212

Radiant Research, Columbus

45249

Radiant Research (admin office), Cincinnati

49048

Borgess Diabetes Center, Kalamazoo

Borgess Research Institute, Kalamazoo

60564

Suburban Clinical Research, Naperville

60624

Suburban Clinical Research, Chicago

63141

Mercy Health Research, St Louis

68114

Quality Clinical Research, Inc., Omaha

71203

Arthritis and Diabetes Clinic, Inc., Monroe

73112

Sooner Clinical Research, Oklahoma City

73120

The Office of Veronique Sebastian, MD, Oklahoma City

75390

University of Texas Southwestern Medical Center at Dallas, Dallas

77030

Houston Neurocare, Houston

77062

Centex Research, Inc., Houston

85004

Clinical Research Consortium, Phoenix

85023

Arizona Research Center, Phoenix

85032

Advanced Podiatry, Phoenix

Precision Trials, Phoenix

85053

The Office of Joshua D. Holland, M.D., Phoenix

85395

Dedicated Clinical Research, Goodyear

85704

Genova Clinical Research, Tucson

89119

Clinical Research Consortium, Las Vegas

Mirkil Medical Group, Las Vegas

V.Jerome Mirkil, MD, Las Vegas

90015

HealthCare Partners Medical Group, Los Angeles

90033

IDS Pharmacy, Los Angeles

University of Southern California, Los Angeles

90057

National Research Institute, Los Angeles

90712

Center for United Research, Inc., Lakewood

93710

Neuro-Pain Medical Center, Fresno

94598

Diablo Clinical Research, Inc., Walnut Creek

97504

Sunstone Medical Research, LLC, Medford

06320

Coastal Connecticut Research, LLC, New London

Neurological Group, PC, New London

06708

Chase Medical Research, LLC, Waterbury

02301

Beacon Clinical Research, LLC, Brockton

Miray Medical Center, Brockton

02720

Genesis Clinical Research, LLC, Fall River

100 00

Clintrial, s.r.o., Prague

150 06

Fakultni nemocnice v Motole, Prague

00133

Fondazione PTV Policlinico Tor Vergata di Roma, Roma

211 52

Center for Lakemedelsstudier, Malmo

111 57

Citydiabetes, Stockholm

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01455415 - Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain | Biotech Hunter | Biotech Hunter